NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations

Aberrations of Phosphoinositide 3-kinase (PI3K)/AKT signaling are frequently observed in many types of cancer, promoting its emergence as a promising target for cancer treatment. PI3K can become activated by various pathways, one of which includes RAS. RAS can not only directly activate the PI3K/AKT...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: PARK, EUNJU, PARK, JINAH, HAN, SAE-WON, IM, SEOCK-AH, KIM, TAE-YOU, OH, DO-YOUN, BANG, YUNG-JUE
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2011
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3584651/
https://ncbi.nlm.nih.gov/pubmed/22159814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2011.1290
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items